Holen Sie sich die Stockscreener-App
9.075
0.33%
-0.095
Schlusskurs vom Vortag:
$8.98
Offen:
$9.03
24-Stunden-Volumen:
84,361
Relative Volume:
0.08
Marktkapitalisierung:
$11.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-67.28M
KGV:
-0.0959
EPS:
-94.66
Netto-Cashflow:
$-9.80M
1W Leistung:
+14.16%
1M Leistung:
+113.10%
6M Leistung:
+44.82%
1J Leistung:
+78.86%
1-Tages-Spanne:
$8.88
$9.86
1-Wochen-Bereich:
$7.80
$15.82
52-Wochen-Spanne:
$2.098
$23.01
Portage Biotech Inc Stock (PRTG) Company Profile
Firmenname
Portage Biotech Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRTG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
9.1956 | 11.11M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.64 | 124.91B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.23 | 60.05B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
603.50 | 35.88B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.79 | 29.83B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.20 | 24.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-03-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-21 | Eingeleitet | Oppenheimer | Outperform |
| 2021-09-02 | Eingeleitet | B. Riley Securities | Buy |
| 2021-08-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Aktie (PRTG) Neueste Nachrichten
Portage Biotech Inc (PRTG) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
PRTG Stock on the Rise: A Promising Investment - investchronicle.com
Short Interest in Portage Biotech Inc. (NASDAQ:PRTG) Rises By 2,134.8% - Defense World
SoftBank Group (OTCMKTS:SFTBF) Stock Crosses Below 200-Day Moving Average – What’s Next? - Defense World
iAnthus Capital Holdings, Inc. (OTCMKTS:ITHUF) Short Interest Up 2,600.0% in March - Defense World
Corning Natural Gas (OTCMKTS:CNIG) Shares Pass Below 200-Day Moving Average – Here’s What Happened - Defense World
Scorpio Gold (OTCMKTS:SRCRF) Share Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World
Portage Biotech (PRTG) Resumes Key Clinical Trial Phase - GuruFocus
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Nasdaq Gains Over 50 Points; JPMorgan Posts Upbeat Earnings - Benzinga
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX - Yahoo Finance
CVS Health Corporation (CVS): A Bull Case Theory - Yahoo Finance
Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts - Yahoo Finance
ImmunityBio, Inc. (IBRX): Among Stocks Under $10 that Will Triple - Yahoo Finance
Cannara Biotech Inc.'s (CVE:LOVE) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Yahoo Finance
Augustine Therapeutics appoints Industry Veteran Pascale Witz as Chair of its Board of Directors - Yahoo Finance
General Oncology Appoints Seasoned Biotech Executive Abid Ansari as Chief Financial Officer - Yahoo Finance
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Small Cap Stocks To Add to Your WatchlistMarch 29th - MarketBeat
Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - Asianet Newsable
Portage Biotech Insider Buyers See Boost After Market Cap Rose US$9.0m - simplywall.st
Promising Biotech Stocks To Watch Now – March 28th - Defense World
Portage Biotech (NASDAQ:PRTG) vs. Cytokinetics (NASDAQ:CYTK) Head-To-Head Survey - Defense World
Biotech Firms Celebrate Gains With Promising Trials And Partnerships - Finimize
Satellos Bioscience (TSE:MSCL) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Why Is Portage Biotech Stock Skyrocketing Friday? - Benzinga
Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher - Benzinga
Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Benzinga
Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews
Portage Biotech (PRTG) Shares Skyrocket In Pre-Hour Trading - Stocks Telegraph
Why Braze Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Benzinga
PRTG Soars On Mesothelioma Data, NVNO Awaits FDA Decision, CureVac Jumps On Patent News - RTTNews
Portage Biotech Shares Jump Premarket After 'Promising' Preclinical Results in Mesothelioma - Marketscreener.com
Portage Biotech Reports Promising Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7 - The Manila Times
Portage Biotech presents preclinical data for PORT-7 - TipRanks
Portage Biotech reports promising mesothelioma treatment data By Investing.com - Investing.com Australia
Portage Reports 'Promising' Preclinical Results in Mesothelioma - MarketScreener
Portage Biotech Announces Promising Preclinical Results for PORT-7 in Mesothelioma - TipRanks
Portage Biotech Reports Promising Preclinical Results In Mesothelioma Supporting First-In-Human Trial Of Port-7 - MarketScreener
Portage Biotech reports promising mesothelioma treatment data - Investing.com
Portage Biotech stock soars on promising preclinical data - Investing.com
Portage Biotech stock soars on promising preclinical data By Investing.com - Investing.com Canada
Game-Changing Mesothelioma Treatment: New Drug Achieves 90% Tumor Reduction in Latest Study - Stock Titan
LINKBANCORP, INC. Announces Receipt of Regulatory Approvals for New Jersey Branch Sale - Yahoo Finance
Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance
Cannara Biotech Announces Appointment of Justin Cohen to Board of Directors - Yahoo Finance
Atea Pharmaceuticals, Inc. (AVIR): A Bull Case Theory - Yahoo Finance
Finanzdaten der Portage Biotech Inc-Aktie (PRTG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
2.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):